Table 3.
Multivariable logistic regression to test for associations between corticosteroid prescription and poor outcome, within temporal endotype group. A separate model was fit for each temporal endotype group.
| Mortality | Complicated Course | ||||||
|---|---|---|---|---|---|---|---|
|
| |||||||
| Group | Variable | O.R. | 95% C.I. | P value | O.R. | 95% C.I. | P value |
| AA | Corticosteroids | 15.0 | 2.8 – 80.8 | 0.002 | 2.9 | 1.0 – 7.9 | 0.043 |
| PRISM | 1.1 | 1.0 – 1.1 | 0.219 | 1.1 | 1.0 – 1.1 | 0.039 | |
| Age | 0.8 | 0.6 – 1.1 | 0.243 | 0.9 | 0.7 – 1.1 | 0.226 | |
| Co-morbidity | 3.4 | 0.6 – 18.5 | 0.162 | 1.8 | 0.6 – 5.7 | 0.329 | |
| AB | Corticosteroids | 2.3 | 0.5 – 11.5 | 0.299 | 2.0 | 0.6 – 6.7 | 0.236 |
| PRISM | 1.1 | 1.0 – 1.2 | 0.059 | 1.1 | 1.0 – 1.2 | 0.019 | |
| Age | 1.2 | 1.0 – 1.5 | 0.109 | 1.0 | 0.9 – 1.3 | 0.599 | |
| Co-morbidity | 0.6 | 0.0 – 3.3 | 0.525 | 0.6 | 0.2 – 2.2 | 0.425 | |
| BB | Corticosteroids | 1.2 | 0.2 – 7.3 | 0.862 | 0.8 | 0.3 – 1.9 | 0.637 |
| PRISM | 1.1 | 1.0 – 1.2 | 0.008 | 1.1 | 1.0 – 1.1 | <0.001 | |
| Age | 1.0 | 0.8 – 1.3 | 0.946 | 1.0 | 0.8 – 1.1 | 0.422 | |
| Co-morbidity | 3.0 | 0.5 – 16.6 | 0.212 | 1.2 | 0.5 – 2.6 | 0.724 | |
| BAa | Corticosteroids | -- | -- | -- | 0.9 | 0.2 – 4.0 | 0.858 |
| PRISM | -- | -- | -- | 1.1 | 1.0 – 1.2 | 0.113 | |
| Age | -- | -- | -- | 1.0 | 0.7 – 1.2 | 0.714 | |
| Co-morbidity | -- | -- | -- | 1.0 | 0.2 – 4.5 | 0.966 | |
a
Analysis for mortality not performed because there was only one death among the subjects assigned to the BA group.